GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NanoVibronix Inc (STU:56R0) » Definitions » Ending Cash Position

NanoVibronix (STU:56R0) Ending Cash Position : €2.48 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NanoVibronix Ending Cash Position?

NanoVibronix's Ending Cash Position for the quarter that ended in Mar. 2024 was €2.48 Mil.

NanoVibronix's quarterly Ending Cash Position declined from Sep. 2023 (€3.55 Mil) to Dec. 2023 (€3.01 Mil) and declined from Dec. 2023 (€3.01 Mil) to Mar. 2024 (€2.48 Mil).

NanoVibronix's annual Ending Cash Position declined from Dec. 2021 (€6.85 Mil) to Dec. 2022 (€2.56 Mil) but then increased from Dec. 2022 (€2.56 Mil) to Dec. 2023 (€3.01 Mil).


NanoVibronix Ending Cash Position Historical Data

The historical data trend for NanoVibronix's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoVibronix Ending Cash Position Chart

NanoVibronix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.20 6.19 6.85 2.56 3.01

NanoVibronix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.41 0.23 3.55 3.01 2.48

NanoVibronix Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

NanoVibronix's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=2.488+0.523
=3.01

NanoVibronix's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=3.021+-0.537
=2.48


NanoVibronix Ending Cash Position Related Terms

Thank you for viewing the detailed overview of NanoVibronix's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


NanoVibronix (STU:56R0) Business Description

Traded in Other Exchanges
Address
525 Executive Boulevard, Elmsford, New York, NY, USA, 10523
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

NanoVibronix (STU:56R0) Headlines

No Headlines